Dissertation/Thesis Abstract

Role of Complement Regulatory Protein Properdin in Complement Activation on Platelets and in the Formation of Platelet-Leukocyte Aggregates
by Saggu, Gurpanna, Ph.D., The University of Toledo, 2014, 210; 3635908
Abstract (Summary)

Patients with inflammatory cardiovascular disease have an increased number of circulating activated platelets and platelet-leukocyte aggregates (PLAs), both of which play a central role in the initiation and progression of disease. Activated platelets can activate the complement system on their surface, with potential consequences in vascular inflammation and thrombosis. Properdin, a positive regulator of the alternative pathway (AP) of complement, is produced mainly by stimulated leukocytes. The mechanisms by which properdin participates in complement activation on platelets and in PLA formation remain unknown. We have shown that the physiological forms of human properdin bind directly to activated, but not resting, platelets. The binding of properdin promotes AP complement activation on activated platelets, as measured by C3b and C9 deposition on their surface, by forming novel C3 convertases on the platelet [C3(H2O),Bb]. Removal of surface proteins by treating platelets with a low dose of proteinase K, leads to reduced properdin binding to activated platelets. On the other hand, chondroitin sulfate-A (a glycosaminoglycan that is released by platelets upon activation) increases the binding of properdin to activated platelets by ~4 fold. These results suggest that interaction of properdin with activated platelets may depend on a protein receptor as well as glycosaminoglycans (i.e. proteoglycans). We have also determined that properdin released by PMA-stimulated neutrophils binds to activated platelets. Since activated neutrophils and platelets directly interact with one another in pro-inflammatory microenvironments, the fresh properdin produced by neutrophils would be available to platelets at high concentrations. Using ex-vivo whole blood assays, we show that properdin leads to an increase in PLA formation in TRAP (thrombin receptor activating peptide)-stimulated whole blood and inhibition of properdin leads to decrease in PLA formation. Our data also show that properdin-mediated PLA formation is controlled by complement regulatory protein factor H. Altogether, the results support a role for properdin in the cellular microenvironment, contributing to complement activation on activated platelets and PLA formation, with potential consequences in inflammation pathophysiology.

Indexing (document details)
Advisor: Ferreira, Viviana P.
Commitee: Pan, Kevin, Stepkowski, Stanislaw, Vazquez, Guillermo, Wooten, Mark
School: The University of Toledo
Department: College of Medicine
School Location: United States -- Ohio
Source: DAI-B 76/01(E), Dissertation Abstracts International
Subjects: Biology, Immunology
Keywords: Alternative pathway, Complement, Factor h, Platelet-leukocyte aggregates, Platelets, Properdin
Publication Number: 3635908
ISBN: 978-1-321-17244-7
Copyright © 2020 ProQuest LLC. All rights reserved. Terms and Conditions Privacy Policy Cookie Policy